NL-OMON39493已完成3 期
ong-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism - a randomized open label study - Longheva
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
Trial is onging in other countries
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients with cancer and confirmed PE or DVT of the leg who have been treated for minimally 6 and maximally 12 months with therapeutic doses of anticoagulants, i.e. LMWH or VKA or a new anticoagulant in a trial
- •2. Written informed consent
- •3. Indication for long-term anticoagulant therapy (e.g. because of metastasized disease, chemotherapy)
排除标准
- •1.* 18 years of age or below the legal age of consent as per country specific regulations
- •2. Indications for anticoagulant therapy other than DVT or PE
- •3. Any contraindication listed in the local labeling of enoxaparin, dalteparin, tinzaparin, nadroparin, warfarin, acenocoumarol or fenprocoumon
- •4. Childbearing potential without proper contraceptive measures, pregnancy or breastfeeding
- •5. Life expectancy of less than 3 months
研究者
相似试验
已完成
不适用
Selecting cancer patients for treatment using Tumor Organoids, the SENSOR studycolon cancerColorectal cancerlung cancernon-small cell lung cancerNL-OMON46891ederlands Kanker Instituut61
已完成
不适用
MEDIASTINAL STAGING OF NON SMALL CELL LUNG CANCER BY ENDOBRONCHIAL AND ENDOSCOPIC ULTRASONOGRAPHY WITH OR WITHOUT ADDITIONAL SURGICAL MEDIASTINOSCOPY (MEDIASTrial)lung cancernon-small cell lung cancerNL-OMON52981Maxima Medisch Centrum356
已完成
4 期
ong-term follow-up and cross-over of treatment with high-density micropulse laser and half-dose photodynamic therapy in participants of the PLACE trial for chronic central serous chorioretinopathy.Chronic central serous chorioretinopathy10047060NL-OMON40728eids Universitair Medisch Centrum92
已完成
不适用
A multicentre Prospective study in pAtients undergoing ventral herNia repair by open approach with intrA-peritoneal positioning using parietex* Composite vEntral pAtch.hernia / abdominal wall defect10041297NL-OMON40149Covidien8
已完成
不适用
An open-label, adaptive multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of RO7234292 in csf and plasma, and safety and tolerability following intrathecal administration in patients with Huntington's disease.Chronic Progressive Choreadegenerative chorea1002929910029317NL-OMON49037Hoffmann-La Roche4